Abstract:Jun Ni, Xun Xi, Sujian Xiao, Xigang Xiao Department of Breast and Thyroid Surgery, People's Hospital of Ganzhou City, Ganzhou, Jiangxi, People's Republic of China Correspondence: Xigang Xiao Department of Breast and Thyroid Surgery, People's Hospital of Ganzhou City, No. 16 Meiguan Road, Ganzhou City, Jiangxi Province, 341000, People's Republic of China Tel/Fax +86-797-5889738 Email Background: Resistance development to paclitaxel (PTX) has become a major obstacle in the successful treatment of breast cancer (BC). Circular RNAs (circRNAs) have been identified as essential regulators in PTX resistance of BC. Here, we explored the precise roles of circRNA homeodomain interacting protein kinase 3 (circHIPK3, circ_0000284) in PTX resistance of BC. Methods: The expression levels of circHIPK3, microRNA (miR)-1286, and hexokinase 2 (HK2) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. Ribonuclease R (RNase R) assay was used to confirm the stability of circHIPK3. Cellular localization of circHIPK3 was assessed by subcellular localization assay. The half maximal inhibitory concentration (IC 50 ) value for PTX was measured by Cell Counting Kit-8 (CCK-8) assay. Cell colony formation, cell cycle distribution, and apoptosis were gauged by colony formation assay and flow cytometry, respectively. Animal studies were performed to evaluate the role of circHIPK3 in vivo. The direct relationship between miR-1286 and circHIPK3 or HK2 was verified by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Results: Our results showed that circHIPK3 was up-regulated in PTX-resistant BC tissues and cells compared with the sensitive counterparts. The silencing of circHIPK3 promoted PTX sensitivity of PTX-resistant BC cells in vitro and in vivo. CircHIPK3 directly targeted miR-1286, and miR-1286 acted as a downstream mediator of circHIPK3 function in vitro. HK2 was a direct target of miR-1286, and circHIPK3 modulated HK2 expression through miR-1286. The increased expression of miR-1286 sensitized PTX-resistant BC cells to PTX in vitro by down-regulating HK2. Conclusion: Our findings demonstrated that the silencing of circHIPK3 sensitized PTX-resistant BC cells to PTX therapy at least in part via the regulation of the miR-1286/HK2 axis. Keywords: chemoresistance, circHIPK3, miR-1286, HK2 Breast cancer (BC) remains the most common type of cancer among women. 1 Paclitaxel (PTX), a type of chemotherapeutic drug taxanes, is an antineoplastic drug, which induces cell death by impacting microtubule stabilization. 2 PTX has been clinically approved and used for BC treatment and is effective against early and metastatic BC. 3 Unfortunately, resistance development to PTX treatment has become a major problem in successful BC treatment. 4 Understanding the molecular basis of PTX resistance is indispensable for improving BC therapies. Covalently closed circular RNAs (circRNAs) are naturally occurring RNA circles that have no free 3ʹ and 5ʹ ends. 5 Many circRNAs involve in post-transcriptional regulation by inhibiting microRNA (miRNA) activity. 6 CircRNAs have been identified as essential regulators in the chemoresistance development of various cancers, including BC. 7 For instance, the overexpression of circ_0005728 contributed to doxorubicin resistance in BC through targeting miR-512-3p. 8 The up-regulation of circ_0001982 induced the development of PTX resistance of BC by the regulation of miR-140-5p. 9 As for circRNA homeodomain interacting protein kinase 3 (circHIPK3, circ_0000284), produced by the back-splicing of HIPK3 mRNA, it has been identified as an oncogenic driver in various cancers, 10 including BC. 11 Importantly, recent evidence highlighted that circHIPK3 could enhance the chemoresistance development of pancreatic cancer and colorectal cancer. 12 , 13 However, the critical role of circHIPK3 in PTX resistance of BC remains to be elucidated. MiRNAs are attractive candidates as upstream modulators of the chemoresistance development because they can control entire sets of genes. 14 , 15 Examples of miRNAs suppressing BC chemoresistance included miR-708-3p and miR-7, which inhibited the translation of their targeted mRNAs. 16 , 17 Conversely, exosome-mediate -Abstract Truncated-

Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286

Comprehensive Profiling of Circrnas and the Tumor Suppressor Function of Circhipk3 in Clear Cell Renal Carcinoma

Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non‐small cell lung cancer via positively modulating KPNA4 by sponging miR‐1298‐5p

Circ_0011292 knockdown mitigates progression and drug resistance in PTX ‐resistant non‐small‐cell lung cancer cells by regulating miR ‐433‐3p/ CHEK1 axis

Hsa_circ_0092276 Promotes Doxorubicin Resistance In Breast Cancer Cells By Regulating Autophagy Via Mir-348/Atg7 Axis

CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p/CDH19 in triple-negative breast cancer

CircRNA_0044556 affects the sensitivity of triple-negative breast cancer cells to paclitaxel by regulating miR-665

Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network

Circcelsr1 (Hsa-Circ-0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression Via Mir-1252

Hsa_circ_0000199 Facilitates Chemo-Tolerance of Triple-Negative Breast Cancer by Interfering with Mir-206/613-led PI3K/Akt/mTOR Signaling.

CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‐185‐5p/BMF axis

CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis

CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC)

Circ_0011385 increases cisplatin resistance in breast cancer via miR-615-5psuppression

Knockdown of Circular RNA Hsa_circ_0000714 Can Regulate RAB17 by Sponging miR-370-3p to Reduce Paclitaxel Resistance of Ovarian Cancer Through CDK6/RB Pathway

A Novel circ_0104345/miR-876-3p/ZBTB20 Axis Regulates the Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells

Exosome‐transported circ_0001955 as a potent driver of breast cancer by regulating the miR‐708‐5p/PGK1 axis

Paclitaxel Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating Circ-BIRC6/miR-877-5p/ YWHAZ Axis

circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade

Circular RNA circPLK1 promotes breast cancer cell proliferation, migration and invasion by regulating miR-4500/IGF1 axis

Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer